Your email has been successfully added to our mailing list.

×
0 0 0.00121129532894236 -0.0105231281701871 -0.00495874025285791 -0.000681353622530119 -0.000681353622530119 -0.000681353622530119
Stock impact report

Acelyrin stock plunges after positive Phase II data readout in thyroid eye disease [Yahoo! Finance]

Amgen Inc. (AMGN) 
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
Company Research Source: Yahoo! Finance
The results failed to impress investors, leading to an 18% drop in after-hours trading following the 6 January announcement. The stock price plunge continued through the day on 7 January, eventually closing more than 36% lower than the previous day. The company highlighted “clinically meaningful” improvements in symptoms, including reductions in eyeball bulging (proptosis), clinical activity score (CAS) and double vision. In the Phase I/II trial (NCT05683496), seven out of eight patients given a 50 mg loading dose followed by 25 mg weekly administration showed improvement in proptosis within 12 weeks, according to the 6 January company presentation. Acelyrin also emphasised that lonigutamab could be safer than Amgen's Tepezza (teprotumumab) – curre Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Created with Highstock 5.0.1230sec1m5m10m30m60m90m120m-1.50%-1.00%-0.50%0.00%0.50%
Opt-in for
AMGN alerts

from News Quantified
Opt-in for
AMGN alerts

from News Quantified